2m 2m 2m 2m 2m 2m 2m
C4 THERAPEUTICS (CCCC)
NASDAQ
$3.50-$0.01 (-0.40%)
Price as of Sep 11, 2026 7:30 PM EDT- $431.8MMarket Cap
- 31.95%1-Year Change
- BiotechnologyIndustry
C4 THERAPEUTICS (CCCC)
$3.50-$0.01 (-0.40%)
CCCC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.51 | ||
Change | +$0.11 (+3.24%) | ||
Open | $3.48 | ||
High | $3.52 | ||
Low | $3.35 | ||
Previous Close | $3.40 | ||
Volume | 1,482,304 | ||
30-Day Average Volume | 2,225,703 | ||
1-Week Change | -6.65% | ||
1-Month Change | -9.30% | ||
1-Year Change | 31.95% | ||
3-Year Change | 48.10% | ||
5-Year Change | -92.84% | ||
Fundamentals | |||
Shares Outstanding | 123.0M | ||
Total Assets | $359.4M | ||
Market Cap | $431.8M | ||
Enterprise Value | $353.2M | ||
Period: QTR TTM FY | |||
Revenue | $6.6M | ||
Net Income | -$23.6M | ||
Free Cash Flow | -$1.6M | ||
EBIT | -$23.6M | ||
EBITDA | -$23.3M | ||
Net Working Capital | $214.7M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 53 | ||
P/B | 2 | ||
P/E | -20 | ||
PEG | -2 | ||
Price/Free Cash Flow | -268 | ||
Price/Operating Cash Flow | -274 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue